共 50 条
Evaluation of Insecticide Resistance in Aedes albopictus (Diptera: Culicidae) in North Carolina, 2017
被引:8
|作者:
Richards, Stephanie L.
[1
]
White, Avian V.
[1
]
Byrd, Brian D.
[2
]
Reiskind, Michael H.
[3
]
Doyle, Michael S.
[4
]
机构:
[1] East Carolina Univ, Environm Hlth Sci Program, Dept Hlth Educ & Promot, Coll Hlth & Human Performance, 3403 Carol Belk Bldg,300 Curry Court, Greenville, NC 27858 USA
[2] Western Carolina Univ, Environm Hlth Sci Program, 3971 Little Savannah Rd,CHHS 416, Cullowhee, NC 28723 USA
[3] North Carolina State Univ, Dept Entomol & Plant Pathol, Campus Box 7613,Gardner Hall, Raleigh, NC 27695 USA
[4] North Carolina Dept Hlth & Human Serv, Div Publ Hlth, Communicable Dis Branch, 225 N McDowell St, Raleigh, NC 27603 USA
关键词:
CDC bottle bioassay;
pyrethroid;
organophosphate;
active ingredient;
formulated product;
LA-CROSSE ENCEPHALITIS;
MOSQUITO-CONTROL;
VIRUS;
TRISERIATUS;
BIFENTHRIN;
IMPACT;
D O I:
10.1093/jme/tjy216
中图分类号:
Q96 [昆虫学];
学科分类号:
摘要:
Mosquitoes may develop resistance to insecticide active ingredients (AIs) found in formulated products (FPs) due to environmental exposure from insecticides in mosquito control and/or unrelated to mosquito control, e.g., agricultural, household pest control. Mosquito control programs should implement resistance management strategies by assessing resistance in targeted populations, rotating different classes of insecticides based on resistance testing, and/or increasing insecticide concentration (i.e., saturation, using maximum labeled rate) to overcome emerging resistance. Resistance testing is often done solely on AIs, but should, in some cases, include both AIs and FPs at the concentrations mosquitoes may encounter in the field. The resistance/susceptibility status was determined for adulticides used in mosquito control. Centers for Disease Control and Prevention (CDC) bottle bioassays were used to assess resistance/susceptibility status for eight AIs (i.e., bifenthrin, permethrin, sumethrin/prallethrin, deltamethrin, tau-fluvalinate, chlorpyrifos, malathion, and naled) and eight FPs (TalStar, Biomist 3 + 15, Duet, Suspend Polyzone, Mavrik, MosquitoMist, Fyfanon, and Dibrom) that respectively contain the AIs. Current CDC guidelines were utilized: susceptible (97-100% mortality at diagnostic time [DT]), developing resistance (90-96% mortality at DT), or resistant (< 90% mortality at DT). Significant differences were observed in mosquito susceptibility/resistance among and between AIs and FPs.
引用
收藏
页码:761 / 773
页数:13
相关论文